3 recruiting, 2 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Recruiting 3, Completed 2 |
Follow 2-hydroxybenzylamine: new trials by email Literature Review of 2-hydroxybenzylamine trials Research Report on 2-hydroxybenzylamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of an Isolevuglandin Scavenger on Salt Sensitivity of Blood Pressure and Immune Cell Activation in Humans 2-hydroxybenzylamine, Placebo - Salt Sensitivity of Blood Pressure, High Blood Pressure | Phase 2 | Recruiting | Vanderbilt University Medical Center | 20 | 2026-10-30 | 2026-11-04 |
| 2-HOBA in Systemic Lupus Erythematosus 2-HOBA acetate (2-Hydroxybenzlamine acetate), Placebo - Systemic Lupus Erthematosus (SLE) | Phase 2 | Recruiting | Vanderbilt University Medical Center | 42 | 2026-05-15 | 2026-05-22 |
| 2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH) 2-Hydroxybenzylamine, Placebo - Familial Hypercholesterolemia | Phase 2 | Recruiting | Vanderbilt University Medical Center | 72 | 2024-02-14 | 2026-08-07 |
| 2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis 2-HOBA, Placebo - Rheumatoid Arthritis | Phase 2 | Completed | Vanderbilt University Medical Center | 32 | 2022-08-09 | 2026-04-08 |
| 2-Hydroxybenzylamine (2-HOBA) to Prevent Early Recurrence of Atrial Fibrillation After Catheter-based Ablation 2-Hydroxybenzylamine, Placebo - Atrial Fibrillation | Phase 2 | Completed | Vanderbilt University Medical Center | 95 | 2020-05-15 | 2024-11-21 |
Hypertension (2) · Arthritis, Rheumatoid (1) · Atrial Fibrillation (1) · Hyperlipoproteinemia Type II (1) · Inflammation (1) · Lupus Erythematosus, Systemic (1)
Vanderbilt University Medical Center (5)
United States (5)
Ben Shoemaker, MD (1) · MacRae F. Linton, MD (1) · Michelle J Ormseth, MD, MSCI (1) · Michelle Ormseth, MD, MSCI (1)
PMID 11230313, PMID 12147930, PMID 1846122, PMID 1860713, PMID 1879381, PMID 34454591, PMID 3522418, PMID 37534363, PMID 37675576, PMID 41052782
P01HL116263 (1), P01HL174442 (1)